ResearchPod Summary
Cognitive behavioral therapy (CBT) is a standard treatment for major depressive disorder (MDD), yet nearly 50% of patients do not experience significant clinical improvement. Because resources are limited and patients may spend months in ineffective treatment, there is an urgent need to identify objective biomarkers—such as those derived from electroencephalography (EEG)—that can predict which individuals will respond to CBT. This study analyzed EEG data from thirty adults with MDD undergoing a 16-week course of CBT to determine if resting-state spectral power could classify responders and non-responders.
The researchers assessed EEG spectral features at baseline and at the two-week mark of treatment. They identified two primary predictive patterns:
These patterns suggest that responders may have different baseline cognitive control mechanisms and that their brain activity undergoes specific changes during the early phase of CBT that correlate with symptom reduction.
Currently, clinicians often rely on trial-and-error to determine if CBT is the right fit for a patient. These findings suggest that resting-state EEG could serve as a non-invasive, accessible, and objective tool to inform personalized treatment decisions. Specifically, the ability to identify potential non-responders after only two weeks of therapy could allow clinicians to switch patients to alternative interventions much earlier, thereby saving time and optimizing the allocation of scarce mental health resources.
AI-generated third-party summary by ResearchPod. Not official content or an endorsement by the paper authors or affiliated organizations.